Effect of Metoprolol in Post Alcohol Septal Ablation Patients With Hypertrophic Cardiomyopathy

• Status: Recruiting
• Trial end date: 2022-02-01
• Target enrollment: 0
• Participant gender: All

Summary

In this trial, the investigators will assess the effect of metoprolol in patients with hypertrophic cardiomyopathy who underwent alcohol septal ablation. The investigators will evaluate the quality of life, exercise tolerance, echocardiographic parameters and laboratory marker of heart failure and myocardial injury.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University Hospital, Motol
• Treatments: Metoprolol

Criteria

Inclusion Criteria:

• Patients post alcohol septal ablation

• Pressure gradient in left ventricular outflow tract <30 mmHg

• Written consent to participate

Exclusion Criteria:

• History of atrial fibrillation

• Symptoms of Class III or IV of New York Heart Association functional classification

• Permanent pacemaker implant

• Age above 75